+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human EGFR Gene Mutation Detection Kit Market by Detection Technique (Next Generation Sequencing, Pcr Based Assays), Product Type (Kits, Reagents and Consumables), End User, Application, Sample Type - Global Forecast 2025-2030- Product Image
Human EGFR Gene Mutation Detection Kit Market by Detection Technique (Next Generation Sequencing, Pcr Based Assays), Product Type (Kits, Reagents and Consumables), End User, Application, Sample Type - Global Forecast 2025-2030- Product Image
New

Human EGFR Gene Mutation Detection Kit Market by Detection Technique (Next Generation Sequencing, Pcr Based Assays), Product Type (Kits, Reagents and Consumables), End User, Application, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145544
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The human epidermal growth factor receptor (EGFR) gene mutation detection kit has emerged as a cornerstone of precision oncology, enabling clinicians and researchers to identify actionable genetic alterations with high reliability. By focusing on the molecular underpinnings of various malignancies, these kits facilitate early diagnosis, inform targeted therapy selection, and monitor treatment response. Recent advancements in assay sensitivity and specificity have accelerated adoption across clinical diagnostic laboratories and research settings, underscoring the critical role of accurate mutation detection in improving patient outcomes.

As the landscape evolves, stakeholders are navigating a convergence of technological breakthroughs, regulatory enhancements, and strategic collaborations that collectively shape the trajectory of EGFR mutation testing. Moreover, the growing emphasis on companion diagnostics linked to targeted therapies has elevated the clinical relevance of these kits, driving demand and fueling competition among assay developers. In this introduction, we explore how foundational principles of molecular diagnostics, combined with robust analytical performance, position the EGFR mutation detection kit as a pivotal tool for personalized medicine.

Charting the Transformative Shifts in EGFR Gene Mutation Detection Landscape Driven by Technological Innovation and Clinical Demand Trends

Over the last decade, the human EGFR gene mutation detection market has undergone transformative shifts driven by relentless innovation and evolving clinical requirements. Initially dominated by polymerase chain reaction methodologies, the landscape has rapidly pivoted toward high-throughput next generation sequencing platforms, which deliver comprehensive mutation profiling in a single workflow. This technological migration has not only expanded the detectable mutation spectrum but also reduced turnaround times, empowering clinicians with more timely insights.

Furthermore, the integration of bioinformatics pipelines into diagnostic workflows has enhanced data interpretation, enabling more accurate discrimination between driver and passenger mutations. Coupled with improved reagent chemistries and automated sample processing, these advancements have collectively raised the bar for assay performance. As a result, industry participants are forging strategic partnerships and investing in cross-functional research to consolidate their market positions, ensuring that end users benefit from the most advanced detection capabilities available.

Evaluating the Cumulative Impact of United States Tariffs on EGFR Mutation Detection Kit Supply Chains and Industry Partnerships in 2025

In 2025, the imposition of new United States tariffs has created ripples across the supply chain for EGFR gene mutation detection kits, affecting both raw material sourcing and finished goods distribution. Reagent manufacturers reliant on imported enzymes and oligonucleotide synthesis reagents have encountered increased input costs, prompting them to re-evaluate supplier portfolios and negotiate localized production agreements. Consequently, some end users have faced longer lead times as suppliers adapt to tariff-induced realignments.

Despite these challenges, many manufacturers have leveraged regional manufacturing hubs and economies of scale to mitigate cost pressures. By optimizing inventory strategies and engaging in forward contracts for critical reagents, companies have preserved margin stability while sustaining product availability. Meanwhile, collaborative efforts between device developers and local regulatory bodies have expedited approval pathways, ensuring that innovation continues to flow even amid tariff-related complexities.

Unraveling Key Segmentation Insights Across Detection Methodologies, Product Classifications, End User Profiles, Application Niches, and Sample Source Variations

The human EGFR gene mutation detection market can be dissected through multiple lenses to uncover nuanced opportunities. When examining detection technique, the shift from traditional PCR based assays toward next generation sequencing reflects a broader demand for multiplexed mutation analysis and comprehensive genomic coverage. This evolution has been particularly pronounced in high-volume diagnostic laboratories seeking to consolidate workflows and reduce per-sample costs.

Product type segmentation further clarifies market dynamics, with kits serving as turnkey solutions for targeted mutation panels, while reagents and consumables-comprising enzymes, primers, and probes-offer modular flexibility for custom assay development. Research institutes and contract research organizations value this modularity to design specialized protocols, whereas diagnostic laboratories and hospital-based clinics favor ready-to-use kits to streamline clinical operations.

End user profiles reveal that academic and government research laboratories drive method innovation and early validation of novel biomarkers, while hospitals and diagnostic centers emphasize assay robustness and regulatory compliance. Companion diagnostics applications have bolstered adoption in clinical settings, complementing research use only platforms employed by academic investigators. Sample type variations, from liquid biopsy approaches that detect circulating tumor cells and circulating tumor DNA to tissue-based workflows using formalin fixed paraffin embedded and fresh frozen specimens, underscore the need for assays with adaptable input requirements and consistent performance across diverse matrices.

Comprehensive Regional Dynamics and Market Penetration Trends Shaping EGFR Mutation Detection Adoption Across Major Geographies

Regional dynamics play a pivotal role in shaping the EGFR gene mutation detection kit ecosystem. In the Americas, a well-established healthcare infrastructure and supportive reimbursement frameworks have accelerated integration of advanced genomic assays into routine diagnostics. Stakeholders in North America leverage extensive clinical trial networks and robust regulatory pathways to pilot novel detection approaches.

Meanwhile, the Europe, Middle East & Africa region exhibits heterogeneous adoption patterns, with Western European markets characterized by early uptake of next generation sequencing panels, supported by centralized laboratories and cross-border collaborations. In contrast, emerging markets across the Middle East and Africa are focusing on foundational PCR based testing to address immediate diagnostic needs, with growing investment in local laboratory capabilities and training initiatives.

Across Asia-Pacific, demand is surging as healthcare systems prioritize precision medicine initiatives. Governments and private entities are establishing genomic centers of excellence, facilitating rapid technology transfer and local manufacturing of kits and reagents. This strategic focus is complemented by public-private partnerships aimed at expanding access to molecular diagnostics and driving down unit costs through large-volume procurement agreements.

Analyzing the Strategies of Leading Players and Innovative Specialists Shaping the EGFR Gene Mutation Detection Kit Market

A diverse set of industry leaders and emerging players are driving growth and innovation within the EGFR gene mutation detection kit domain. Established diagnostics giants have leveraged their global distribution networks and regulatory expertise to introduce integrated workflow solutions that span sample preparation, sequencing, and data analysis. These companies continue to invest in next generation sequencing platform enhancements and reagent optimization to deliver superior sensitivity for low-abundance mutations.

At the same time, specialized molecular diagnostics firms and reagent suppliers have focused on developing high-fidelity enzymes and multiplex primer-probe panels tailored to EGFR mutation hotspots. Their agility in updating assay designs in response to newly discovered variants has won them increased favor among research institutes seeking cutting-edge tools. Collaborative ventures between kit manufacturers and software providers have also emerged, combining assay data with advanced bioinformatics analytics to streamline interpretation and clinical reporting.

Crafting Actionable Strategies for Industry Leaders to Enhance Assay Innovation, Streamline Supply Chains, and Expand Market Reach

Industry leaders should prioritize strategic investments in assay automation and data integration to maintain a competitive edge in the evolving EGFR mutation detection landscape. By forging alliances with reagent innovators, kit developers can accelerate the validation of next generation sequencing-based panels that encompass emerging resistance mutations. Additionally, optimizing manufacturing footprints through regional production partnerships will mitigate tariff-induced supply disruptions and reduce lead times for key reagents.

Engaging with clinical and academic collaborators to generate real-world evidence will strengthen the clinical utility narrative and facilitate reimbursement discussions. Furthermore, offering modular product configurations that cater to both high-throughput laboratories and smaller diagnostic centers can broaden market reach. Finally, investing in user-friendly bioinformatics platforms will enhance data transparency and empower end users to extract actionable insights with minimal training.

Methodical Research Framework Leveraging Primary Interviews, Secondary Intelligence, and Data Triangulation for Robust Market Insights

This research report synthesizes primary and secondary data sources to deliver comprehensive insights into the human EGFR gene mutation detection kit market. Primary research involved in-depth interviews with key opinion leaders, laboratory directors, and technical specialists across major regions to capture real-world perspectives on assay performance and adoption hurdles. Secondary research encompassed a systematic review of peer-reviewed publications, regulatory filings, and industry white papers to map technological advancements and competitive landscapes.

Data triangulation techniques were employed to validate findings and ensure consistency between qualitative stakeholder feedback and quantitative trend indicators. Rigorous cross-verification of company announcements, patent filings, and clinical trial databases underpins the accuracy of competitive intelligence. This multifaceted methodology ensures that strategic recommendations are grounded in current market realities and aligned with emerging scientific developments.

Concluding Perspectives on Technological Evolution, Supply Chain Resilience, and Strategic Alignment in EGFR Mutation Detection Ecosystem

In summary, the human EGFR gene mutation detection kit market stands at the intersection of technological innovation and clinical imperative. The transition toward high-throughput sequencing platforms, complemented by modular reagent offerings, reflects a maturing industry poised for further growth. While tariff considerations have introduced supply chain complexities, strategic localization of manufacturing and proactive inventory management have demonstrated resilience against cost pressures.

As end users demand faster, more comprehensive mutation profiling, the ability to deliver accurate, reproducible results across diverse sample types will be paramount. By understanding regional adoption nuances and segment-specific requirements, stakeholders can tailor their product portfolios to meet evolving diagnostic and research needs. Ultimately, those who integrate advanced assay technologies with streamlined workflows and actionable clinical evidence will lead the charge in shaping the future of precision oncology diagnostics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Detection Technique
    • Next Generation Sequencing
    • Pcr Based Assays
  • Product Type
    • Kits
    • Reagents And Consumables
      • Enzymes
      • Primers
      • Probes
  • End User
    • Contract Research Organizations
    • Diagnostic Laboratories
    • Hospitals And Clinics
    • Research Institutes
      • Academic Institutions
      • Government Research Laboratories
  • Application
    • Clinical Diagnostics
    • Companion Diagnostics
    • Research Use Only
  • Sample Type
    • Liquid Biopsy
      • Circulating Tumor Cells
      • Circulating Tumor DNA
    • Tissue
      • Formalin Fixed Paraffin Embedded
      • Fresh Frozen
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Siemens Healthineers AG
  • PerkinElmer, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of liquid biopsy assays for real-time monitoring of EGFR mutation status in NSCLC patients
5.2. Emerging use of ultra-sensitive digital PCR platforms for detecting low-frequency EGFR mutations in plasma samples
5.3. Integration of AI-driven bioinformatics software to streamline EGFR mutation data analysis and reduce interpretation time
5.4. Expansion of EGFR mutation testing in emerging markets driven by government-funded cancer screening programs
5.5. Development of multiplex PCR panels enabling simultaneous detection of EGFR mutations and other oncogenic targets in lung cancer
5.6. Growing partnerships between diagnostic kit manufacturers and pharmaceutical companies for personalized EGFR-targeted therapies
5.7. Regulatory approvals of next-generation EGFR mutation assays offering faster turnaround times and higher throughput
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human EGFR Gene Mutation Detection Kit Market, by Detection Technique
8.1. Introduction
8.2. Next Generation Sequencing
8.3. Pcr Based Assays
9. Human EGFR Gene Mutation Detection Kit Market, by Product Type
9.1. Introduction
9.2. Kits
9.3. Reagents And Consumables
9.3.1. Enzymes
9.3.2. Primers
9.3.3. Probes
10. Human EGFR Gene Mutation Detection Kit Market, by End User
10.1. Introduction
10.2. Contract Research Organizations
10.3. Diagnostic Laboratories
10.4. Hospitals And Clinics
10.5. Research Institutes
10.5.1. Academic Institutions
10.5.2. Government Research Laboratories
11. Human EGFR Gene Mutation Detection Kit Market, by Application
11.1. Introduction
11.2. Clinical Diagnostics
11.3. Companion Diagnostics
11.4. Research Use Only
12. Human EGFR Gene Mutation Detection Kit Market, by Sample Type
12.1. Introduction
12.2. Liquid Biopsy
12.2.1. Circulating Tumor Cells
12.2.2. Circulating Tumor DNA
12.3. Tissue
12.3.1. Formalin Fixed Paraffin Embedded
12.3.2. Fresh Frozen
13. Americas Human EGFR Gene Mutation Detection Kit Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human EGFR Gene Mutation Detection Kit Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human EGFR Gene Mutation Detection Kit Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Qiagen N.V.
16.3.4. Abbott Laboratories
16.3.5. Danaher Corporation
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Agilent Technologies, Inc.
16.3.8. Illumina, Inc.
16.3.9. Siemens Healthineers AG
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET: RESEARCHAI
FIGURE 26. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PCR BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PCR BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY GOVERNMENT RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH USE ONLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH USE ONLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY FORMALIN FIXED PARAFFIN EMBEDDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY FRESH FROZEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY FRESH FROZEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 226. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 227. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 231. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 244. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 245. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 248. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 249. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 254. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 255. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY LIQUID BIOPSY, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 275. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 276. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 277. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 280. ITALY HUMAN EGFR GENE MUTATION DETECTION KIT MARKET SIZE, BY REAGENTS AND CONSUMABLES, 202

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human EGFR Gene Mutation Detection Kit market report include:
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Siemens Healthineers AG
  • PerkinElmer, Inc.

Related Topics

Related Reports

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Technology (Digital Pcr, Next Gen Sequencing, Real Time Pcr), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer), End User, Sample Type, Product Type - Global Forecast 2025-2030 - Product Image

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Technology (Digital Pcr, Next Gen Sequencing, Real Time Pcr), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer), End User, Sample Type, Product Type - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
EGFR Tests Market by Application (Respiratory Cancer), Sample Type (Liquid Biopsy, Tissue Biopsy), Technology, Test Type, End User - Global Forecast 2025-2030 - Product Image

EGFR Tests Market by Application (Respiratory Cancer), Sample Type (Liquid Biopsy, Tissue Biopsy), Technology, Test Type, End User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
EGFR Mutation Test Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

EGFR Mutation Test Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Human Gene Mutation Detection Kit Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Product Type (Instruments, Reagents, Services), Application, End User - Global Forecast 2025-2030 - Product Image

Human Gene Mutation Detection Kit Market by Technology (Microarray, Next Generation Sequencing, Polymerase Chain Reaction), Product Type (Instruments, Reagents, Services), Application, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.